Hypertrophic cardiomyopathy is diagnosed by cardiologists, by integrating various clinical information, including:
The management goals of hypertrophic cardiomyopathy are aimed at improving patient symptoms and reducing the risks of sudden cardiac death.
Common symptoms of hypertrophic cardiomyopathy include shortness of breath and chest pain. Treatment options include:
All patients with hypertrophic cardiomyopathy will undergo risk stratification for sudden cardiac death. Patients at high risks will be counselled for implantation of a cardiac defibrillator.
That saying, a significant proportion of local patients with hypertrophic cardiomyopathy are asymptomatic and are at low risks of sudden death. They do not require specific treatment.
Since hypertrophic cardiomyopathy is a potentially inheritable condition, a detailed family history will be obtained. Patients will be encouraged to undergo genetic counselling and genetic testing, to identify the culprit gene. Family screening for this condition is also encouraged, in first-degree relatives.
The Cardiomyopathy Clinic at the National University Heart Centre, Singapore (NUHCS) provides a comprehensive evaluation and treatment service for patients with hypertrophic cardiomyopathy.
Panel A: Echocardiogram of a normal heart, showing normal thickness of the left ventricular (LV) walls
Panel B: Echocardiogram of a patient with hypertrophic cardiomyopathy, showing markedly thickened LV walls (red arrows)